NICE COVID-19 Rapid guidance
British Society for Rheumatology advice on vaccination for those who are immunosuppressed
Following reports yesterday around the use of the Astra Zenica vaccine for immunosuppressed patients, the BSR want to confirm the JCVI position (as our guidance states) that this vaccine is considered safe for this patient group. More details: bit.ly/2XmOMK6
Urgent and Emergency Musculoskeletal Conditions Requiring Onward Referral
This updated guidance follows the specialist guidance document produced during the first phase of the coronavirus pandemic. The guidance supports primary and community care practitioners in recognising serious pathology which requires emergency or urgent referral to secondary care in a patient who present with new or worsening musculoskeletal (MSK) symptoms.
Guidance from the British Society for Rheumatology
Updated (20th November 2020) guidance for the management of patients with musculoskeletal and rheumatic conditions
An update to the clinical guide for the management of patients with musculoskeletal and rheumatic conditions who are already taking corticosteroids, or require initiation of oral/IV corticosteroids, or require a corticosteroid injection in the context of the COVID-19 pandemic has been published on the British Society of Rheumatology website.
- Identifying patients for shielding from the British Society for Rheumatology
Guidance for self-management of bone, joint and muscle pain from Chartered Society of Physiotherapist
Leaflets available here: http://bit.ly/2XlYsEz